Search clinical trials for: Telatinib
Total 188 results
-
Qilu Pharmaceutical Co., Ltd.UnknownAdvanced Breast CancerChina
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Puma Biotechnology, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterNo longer available
-
Puma Biotechnology, Inc.Completed
-
Pierre Fabre MedicamentNot yet recruiting
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Completed
-
Taizhou EOC Pharma Co., Ltd.Fountain Medical Development Co., Ltd.CompletedSolid Tumor, AdultChina
-
Pierre Fabre Pharma GmbHiOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AGActive, not recruiting
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLCChina
-
Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, HepatocellularChina, Taiwan, Korea, Republic of
-
Convalife (Shanghai) Co., Ltd.Not yet recruiting
-
Hutchison Medipharma LimitedCompleted
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Withdrawn
-
Hutchison Medipharma LimitedTerminated
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedAdvanced Solid CancerChina
-
M.D. Anderson Cancer CenterWithdrawn
-
Virginia Commonwealth UniversityGlaxoSmithKline; Puma Biotechnology, Inc.RecruitingOvarian Cancer | Advanced Solid TumorUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Sun Yat-sen University; Peking University International Hospital; Zhejiang UniversityNot yet recruitingHER2-positive Breast Cancer | Brain MetastasesChina
-
Jules Bordet InstituteWithdrawn
-
Baylor Research InstituteNot yet recruitingBreast Cancer | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Cascadian Therapeutics Inc.Completed
-
Puma Biotechnology, Inc.CompletedHepatic InsufficiencyRussian Federation
-
University Health Network, TorontoRecruitingBreast Cancer | HER2-positive Breast CancerCanada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Puma Biotechnology, Inc.CompletedHealthy SubjectsUnited States
-
NSABP Foundation IncPuma Biotechnology, Inc.Completed
-
Taizhou EOC Pharma Co., Ltd.Shanghai Zhongshan Hospital; Shanghai East HospitalUnknown
-
Puma Biotechnology, Inc.CompletedNeoplasms | Breast NeoplasmsUnited States, Belgium, India, China, Russian Federation, Mexico, France
-
Korea University Guro HospitalKorean Cancer Study GroupActive, not recruitingMetastatic Cancer | HER2 Gene MutationKorea, Republic of
-
Hallym University Medical CenterRecruitingGastric Cancer | Gastroesophageal-junction CancerKorea, Republic of
-
ACT Biotech, IncCompletedGastric CancerSpain, United States
-
Andrew Hendifar, MDEOC PharmaActive, not recruitingHepatocellular Carcinoma | Gastric CancerUnited States
-
Sun Yat-sen UniversityRecruitingRecurrent Hepatocellular CarcinomaChina
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, Korea, Republic of, China, United Kingdom, Canada, France, Australia, Denmark, Switzerland, Japan, Malaysia, Italy, Singapore, Taiwan, Belgium, Croatia, Czechia, Romania, Germany, Bahamas, Brazil, Bulgaria, Colombia and more
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Puma Biotechnology, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States, France, Hungary, Poland, Spain
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHER2-positive Breast Cancer
-
Criterium, Inc.EMD Serono Research & Development Institute, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer With MET MutationsUnited States